Aubagne, France, Goettingen, Germany and Chalfont St. Giles, UK 9/12/11—Sartorius Stedim Biotech and GE Healthcare Life Sciences have signed a patent cross-licensing agreement for biotechnology manufacturing technologies. Sartorius has granted GE a sublicense to certain patents exclusively licensed from Fluorometrix that involve bioreactors with at least two optical sensors. GE has granted Sartorius a sublicense to patent rights it licensed from SciLog for the automated, aseptic transfer of solutions in bioprocessing applications. “In the immediate term it will enable us to employ the technologies covered by the patents in the license agreements to further advance the controls of single-use devices,” commented Catarina Flyborg, general manager, BioProcess Products at GE Healthcare Life Sciences. “Furthermore our customers will profit from the freedom to employ these proprietary control mechanisms, without violating patent rights, when sourced from either GE Healthcare or Sartorius Stedim Biotech.” Financial terms were not disclosed.